Anzeige
Mehr »
Mittwoch, 24.12.2025 - Börsentäglich über 12.000 News
Kein Weihnachtswunder - Blutuntersuchung ohne Blutabnahme!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Business Wire

ZeitAktuelle NachrichtenRatingLeser
MoOtovo Acquires Soly Customers and Assets as it Expands Across Europe216Otovo acquires 24,000 customers and other assets from Soly for an approximately €0.75 million cash consideration Otovo, a leading home energy service provider in the U.S. and Europe, today announced...
► Artikel lesen
MoAnalystenbericht der GBC AG zu Mexedia S.p.A. Società Benefit abgeschlossen und veröffentlicht205Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) ("Mexedia" oder "Unternehmen") gibt bekannt, dass der von der GBC AG einem der führenden unabhängigen Finanzresearch-Unternehmen...
► Artikel lesen
MoQuanterix Corporation: Quanterix Announces Landmark Nature Study Redefining Alzheimer's Disease Neuropathology Prevalence203Simoa p-Tau 217 Assay Enables Largest Population-Based Assessment (11,000+ Samples) Revealing Striking Age-Related Increase and Broad Treatment Eligibility Quanterix Corporation(NASDAQ: QTRX),...
► Artikel lesen
MoLithium Royalty Corp. Agrees to Be Acquired by Altius Minerals Corporation218TORONTO--(BUSINESS WIRE)--Lithium Royalty Corp. (the "Company" or "LRC") (TSX: LIRC) today announced that it has entered into a definitive arrangement agreement (the "Arrangement Agreement") with Altius...
► Artikel lesen
MoXCharge and EnBW Begin Expanded Testing of Fast-Charging Infrastructure284Eleven XCharge units deployed across four locations as part of EnBW's strategic testing program HAMBURG, Germany--(BUSINESS WIRE)--XCharge is cooperating in testing with EnBW on their fast-charging-network...
► Artikel lesen
MoNewron Pharmaceuticals S.p.A.: Newron to Host Investor and Partnering Meetings During the J.P. Morgan Healthcare Conference Week268Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral...
► Artikel lesen
MoVertical Aerospace Doubles Flight Test Capacity With Final Prototype190Final prototype to expand flight test capacity and enable public demonstrations Initial all-electric testing ahead of hybrid-electric flights in 2026 Vertical progresses towards full...
► Artikel lesen
MoNovocure to Present at 44th Annual J.P. Morgan Healthcare Conference151Novocure (NASDAQ: NVCR) announced today that management will participate in the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco on January 12-15, 2026. Frank Leonard, Chief...
► Artikel lesen
MoKolibri Global Energy Inc. Provides Operations Update153Kolibri Global Energy Inc. (the "Company" or "Kolibri") (TSX: KEI, NASDAQ: KGEI) is pleased to provide an operations update on its latest wells in its Tishomingo field in Oklahoma. FIELD UPDATE...
► Artikel lesen
MoAccess Advance LLC: Hisense tritt dem HEVC Advance Patentpool bei170Access Advance LLC, weltweit führend im Bereich der Lizenzierung von Video-Codec-Patentpools, gab heute bekannt, dass Hisense Group Holdings Co., Ltd. dem HEVC Advance Patent Pool als Lizenznehmer...
► Artikel lesen
MoKalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals Announces Approval of EKTERLY (sebetralstat) in Japan, First and Only Oral On-demand Treatment for Hereditary Angioedema198KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing approval for EKTERLY (sebetralstat)...
► Artikel lesen
MoHavas Reports the Progress of Transactions Under Its Current Share Buyback Program250Regulatory News: Havas N.V. (EURONEXT: HAVAS) hereby reports transaction details related to the €50 million buyback program as communicated on May 28, 2025. From December 15, 2025, up to and...
► Artikel lesen
MoZambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson's Disease183Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the...
► Artikel lesen
MoZambon Biotech meldet erste Dosisverabreichung der klinischen Phase-3b-Studie ADIP zu IPX203 bei Parkinson211Zambon Biotech ein spezialisiertes Biotechnologie-Unternehmen der Zambon-Unternehmensgruppe, das den Aufbau eines wissenschaftlich fundierten und wirtschaftlich tragfähigen Portfolios innovativer...
► Artikel lesen
MoAxelspace Corporation: Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch152Axelspace Corporation ("Axelspace"), a leading microsatellite company committed to making "Space within Your Reach," is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global...
► Artikel lesen
MoOmdia: Global Cloud Infrastructure Spending Hits $102.6 Billion, up 25% in Q3 2025218According to new research from Omdia, global spending on cloud infrastructure services reached $102.6 billion in Q3 2025, representing 25% year-on-year growth. Market momentum remained stable, marking...
► Artikel lesen
Moviagogo: The Most Iconic Moments From Lily Allen, Lewis Capaldi, Katy Perry and Drake Revealed in Year in Live Experiences Report268From Lily Allen creating the ultimate diss album, Lewis Capaldi beating Drake and Kendrick, to Katy Perry's space adventure impacting her ticket sales a new report unlocks fans favourite moments in...
► Artikel lesen
MoMerck KGaA: Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor278First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantly improved objective response rate...
► Artikel lesen
MoMerck: Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor289First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantly improved objective response rate...
► Artikel lesen
MoKKR Launches European Rail Leasing Platform with Green Mobility Partners266Strategic partnership to scale newly established locomotive and train leasing company into a leading European rail leasing platform Green Mobility Partners ("GMP"), a Vienna-based electric locomotive...
► Artikel lesen
MoIncyte Japan Announces Approval of Zynyz (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer225Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based...
► Artikel lesen
MoIncyte Japan Announces Approval of Minjuvi (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma217Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi (tafasitamab) in combination with rituximab and lenalidomide for adult...
► Artikel lesen
MoGBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published163Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) ("Mexedia" or the "Company") informs that the analyst coverage report prepared by GBC AG one of...
► Artikel lesen
MoCloudfresh Wins 2025 EMEA GitLab Partner of the Year Award for Emerging Markets in Eastern Europe and Israel190Cloudfresh, a certified GitLab Select and Professional Services Partner and a global leader in delivering multi-vendor cloud solutions, announced today that it has received the 2025 EMEA GitLab Partner...
► Artikel lesen
MoCoty Appoints Markus Strobel Executive Chairman and Interim CEO479Regulatory News: Coty Inc. (NYSE: COTY) (Paris: COTY) ("Coty" or "the Company") today announced that Markus Strobel will become Executive Chairman of the Board and Interim Chief Executive Officer...
► Artikel lesen